Ono Pharmaceutical (OPHLF) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free OPHLF Stock Alerts $15.96 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOno Pharmaceutical (OTCMKTS:OPHLF) Hits New 52-Week Low at $15.96marketbeat.com - April 22 at 8:20 PMHookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalystsseekingalpha.com - April 22 at 5:34 PMQ4 2023 Cue Biopharma Inc Earnings Callfinance.yahoo.com - April 9 at 8:24 AMOno Pharmaceutical Co Ltd (OPHLY)uk.investing.com - March 20 at 4:24 PMDon Lemon Says His Talk Show Deal with X Was Canceled After Tense Interview with Elon Musk: 'He's Mad at Me'msn.com - March 14 at 9:44 AMOno Pharmaceutical Co., - Depositary Receipt () (OPHLY) Price Target Increased by 19.99% to 7.80msn.com - February 24 at 11:07 PMOno Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targetsfinance.yahoo.com - February 22 at 6:56 PMLondon exhibition celebrates 'unknown artist' Yoko Onomsn.com - February 20 at 12:27 AMOno Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteinsuk.finance.yahoo.com - February 14 at 9:16 AMNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancerglobenewswire.com - February 14 at 3:00 AMNVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?msn.com - February 5 at 2:50 PMOno Pharmaceutical Ltd (4528)investing.com - February 5 at 2:50 PMODP: A Value Play With Catalystsseekingalpha.com - January 16 at 1:47 AMSnack Maker Orion Slumps After Pharma Acquisition Pushwsj.com - January 16 at 1:47 AMOno Enters into Research Collaboration with UK Dementia Research Institutetmcnet.com - December 21 at 11:46 PMBioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Researchmarkets.businessinsider.com - December 19 at 7:09 AMOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 29.83% to 7.51msn.com - December 16 at 10:03 AMORIC Pharma NSCLC Brain Metastasis Data Is Highly Interestingseekingalpha.com - December 9 at 10:37 AMOno Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Millionfinance.yahoo.com - December 1 at 9:20 AMU.S. Stocks Open Mostly Lower, With S&P 500 Falling Slightly Ahead Of Fed Speakersfinance.yahoo.com - November 28 at 1:51 PMNikkei Edges Lower on Yen Strength, Likely Position Adjustmentfinance.yahoo.com - November 28 at 8:51 AMNikkei Falls 0.4% Amid JPY Strengthfinance.yahoo.com - November 27 at 8:27 PMOzempic, Wegovy demand drives up illegal sales of weight-loss drugsmsn.com - November 1 at 3:46 PMOno Pharmaceutical Co Ltdmorningstar.com - October 28 at 9:57 AMOno Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Whyfinance.yahoo.com - September 1 at 4:44 PMONO PHARMACEUTICAL is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - July 30 at 12:57 PMUSFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facilitymsn.com - January 27 at 8:27 AMPrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceuticaltechnews.tmcnet.com - December 15 at 3:03 PMPrecisionLife and Ono Pharmaceutical enter multi-year collaborationmsn.com - December 14 at 8:03 AMONO PHARMA USA continues to expand its organization for enhancement of R&D activities and future commercialization opportunities in the U.S.yahoo.com - August 31 at 5:18 AMOno Pharmaceutical GAAP EPS of ¥60.36, revenue of ¥106.72Bseekingalpha.com - August 3 at 10:24 PMFate, Ono expand team up on cancer immunotherapy programseekingalpha.com - June 28 at 11:22 AMOno Pharmaceutical Co. (OPHLF) Upgraded to Strong Buy: What Does It Mean for the Stock?finance.yahoo.com - June 10 at 4:20 PMNeurimmune expands drug discovery collaboration with Ono Pharmaceutical in the field of neurodegenerative diseasesprnewswire.com - January 17 at 5:37 AMOno Pharmaceutical Co. Ltd (OPHLF)nasdaq.com - January 7 at 8:43 AMHere's what Wall Street expects from Ono Pharmaceutical's earningsmarkets.businessinsider.com - November 13 at 8:03 AMHere's what Wall Street expects from Ono Pharmaceutical's earnings reportmarkets.businessinsider.com - July 28 at 12:58 PM Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> OPHLF Media Mentions By Week OPHLF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHLF News Sentiment▼0.060.41▲Average Medical News Sentiment OPHLF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHLF Articles This Week▼20▲OPHLF Articles Average Week Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Context Therapeutics News EOM Pharmaceuticals News Genmab A/S News Grifols News Hypera News IMV News International Stem Cell News LAVA Therapeutics News Mainz Biomed News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OPHLF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
